Plus Therapeutics: Gliblastoma, Rhenium NanoLiposome, and Harnessing the Power of Radiation Therapy
Plus Therapeutics: Gliblastoma, Rhenium NanoLiposome, and Harnessing the Power of Radiation Therapy

Plus Therapeutics: Gliblastoma, Rhenium NanoLiposome, and Harnessing the Power of Radiation Therapy

PRINCEARHAN WORLD

16 min
Knowledge
Play

Description

 <br /><br /><br /><br /><br /><br /> <br /><br />Dr. Marc Hedrick, President and CEO at Plus Therapeutics which is a clinical-stage pharmaceutical company focused on making a positive impact on patients’ lives and adding value to the healthcare system joins eHealth Radio and the Cancer Information and Health News Channels.<br /><br />Listen to interview with host Eric Michaels and guest Dr. Marc Hedrick discuss the following:<br /><br />What is Plus Therapeutics, and what is its mission?<br /><br />Tell us about your background and what brought you to Plus Therapeutics?<br /><br />What is Rhenium NanoLiposome (RNL™) and how is it delivered to cancerous brain tumors?<br /><br />How could RNL help advance current treatment options for GBM and why is this important for patients?<br /><br />Do you think most people understand radiation and its potential benefits as a cancer therapy?<br /><br />What do you think is the most common misconception that people hold about radiation as a cancer treatment?<br /><br />What’s next Plus Therapeutics? Is Plus developing other investigational candidates as part of its broader pipeline?<br /><br />Dr. Marc Hedrick is the President and CEO at PLUS THERAPEUTICS, Inc. Previously, Dr. Hedrick served in a number of executive leadership roles including President, CEO, and Director at Cytori Therapeutics, Inc., and President and CEO of StemSource, Inc. Dr. Hedrick is a trained general, vascular, and plastic surgeon and former Associate Professor of Surgery and Pediatrics at the University of California, Los Angeles (UCLA). Dr. Hedrick also served as Co-Director of the Laboratory of Regenerative Bioengineering and Repair at UCLA. Dr. Hedrick obtained his MD from the University of Texas Southwestern Medical School, Dallas and a MBA from The Anderson School at UCLA in 2005.<br /><br /> <br /><br /><br /><br /> <br /><br />Website: plustherapeutics.com <br /><br />Social Media Links: <br />Facebook: facebook.com/plustherapeutics  <br />Instagram: instagram.com/plustherapeutics  <br />Twitte

Uploader

sammy_surf

sammy_surf

Plus Therapeutics: Gliblastoma, Rhenium NanoLiposome, and Harnessing the Power of Radiation Therapy - Listen Free | WowFM